Biologics Approved In 2010
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Chart lists full licensing approvals for therapeutic biologics, imaging agents and vaccines. FDA transferred review of most therapeutic biologics to the Center for Drug Evaluation & Research on Oct. 1, 2003; products that continue to be reviewed by the Center for Biologics Evaluation & Research, including vaccines, cellular products, antitoxins and immunoglobulins, are designated with an asterisk (*). Diagnostics are not included.